TARSTarsus Pharmaceuticals Inc
TARS
Tarsus Pharmaceuticals Inc909
Mkt Cap
$2.73BVolume
808,345.0052W High
$85.2552W Low
$38.51PE Ratio
-39.84TARS Fundamentals
Price
$64.13Prev Close
$64.51Open
$66.0750D MA
$69.30Beta
0.74Avg. Volume
731,451.64EPS (Annual)
-$1.59P/B
7.95Rev/Employee
$1.22M$3,086.48
Tarsus Pharmaceuticals (NASDAQ:TARS) CEO Sells $761,676.24 in Stock
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) CEO Bobak Azamian sold 10,972 shares of the firm's stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $69.42, for a total value of $761,676.24. Following the completion of the transaction, the...
MarketBeat·4d ago
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Jeffrey Farrow Sells 2,111 Shares
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Jeffrey Farrow sold 2,111 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $69.42, for a total transaction of $146,545.62. Following the transaction, the insider owned 47,635...
MarketBeat·4d ago
Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells 2,186 Shares of Stock
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Jeffrey Farrow sold 2,186 shares of the business's stock in a transaction on Thursday, March 19th. The shares were sold at an average price of $67.00, for a total transaction of $146,462.00. Following the transaction, the insider...
MarketBeat·4d ago
Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells 2,133 Shares of Stock
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Jeffrey Farrow sold 2,133 shares of the stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $68.71, for a total transaction of $146,558.43. Following the completion of the...
MarketBeat·4d ago
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Elizabeth Yeu Lin Sells 390 Shares
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Elizabeth Yeu Lin sold 390 shares of the firm's stock in a transaction on Thursday, March 19th. The shares were sold at an average price of $67.00, for a total value of $26,130.00. Following the sale, the insider directly owned...
MarketBeat·4d ago
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Elizabeth Yeu Lin Sells 375 Shares
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Elizabeth Yeu Lin sold 375 shares of the business's stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $69.42, for a total transaction of $26,032.50. Following the transaction...
MarketBeat·4d ago
Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells $26,041.09 in Stock
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Elizabeth Yeu Lin sold 379 shares of the company's stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $68.71, for a total transaction of $26,041.09. Following the completion of the...
MarketBeat·4d ago
Insider Selling: Tarsus Pharmaceuticals (NASDAQ:TARS) Insider Sells 4,029 Shares of Stock
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Dianne Whitfield sold 4,029 shares of the business's stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $69.42, for a total value of $279,693.18. Following the transaction, the insider owned...
MarketBeat·4d ago
Dianne Whitfield Sells 4,071 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) Stock
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) insider Dianne Whitfield sold 4,071 shares of the stock in a transaction on Wednesday, March 18th. The stock was sold at an average price of $68.71, for a total value of $279,718.41. Following the transaction, the insider owned 39,202...
MarketBeat·4d ago
Tarsus Pharmaceuticals (NASDAQ:TARS) General Counsel Sells $283,428.75 in Stock
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS - Get Free Report) General Counsel Bryan Wahl sold 4,125 shares of the stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $68.71, for a total value of $283,428.75. Following the transaction, the general counsel...
MarketBeat·4d ago
<
1
2
...
>